Dr. Soliman Fakeeh Hospital in Jeddah has achieved a brand new medical milestone by efficiently performing the primary autologous stem cell transplant in Saudi Arabia’s personal healthcare sector for a 55-year-old affected person recognized with a number of myeloma.
This achievement displays the hospital’s continued development in specialised hematology and oncology care and reinforces its place as a number one supplier of superior healthcare companies.
The process marks the launch of the hospital’s Stem Cell Transplantation and Mobile Remedy Program, with its first autologous stem cell transplant efficiently accomplished, demonstrating this system’s readiness to supply extremely specialised therapies in accordance with the most recent worldwide requirements and scientific protocols.
Dr. Mazen Fakeeh, President of Fakeeh Care Group, said that this milestone represents a major step ahead within the Group’s journey towards increasing superior specialised healthcare companies. He famous that it displays Fakeeh Care Group’s ongoing dedication to delivering world-class medical care whereas contributing to the continual development of healthcare high quality within the Kingdom.
Autologous stem cell transplantation stays one of many key remedy modalities for medically eligible sufferers with a number of myeloma. The process includes accumulating the affected person’s personal stem cells following preliminary remedy, administering high-dose chemotherapy to get rid of as many most cancers cells as potential, after which reinfusing the harvested stem cells to revive bone marrow operate and speed up blood cell restoration. This strategy helps obtain deeper remedy responses, lengthen illness management, and enhance sufferers’ high quality of life.
Commenting on the achievement, Dr. Ahmed Alsaeed, Advisor of Hematology and Bone Marrow Transplantation at Dr. Soliman Fakeeh Hospital – Jeddah, stated that the profitable completion of the hospital’s first autologous stem cell transplant displays the establishment’s superior scientific experience, specialised infrastructure, and state-of-the-art services, enabling sufferers to entry this extremely specialised remedy throughout the Kingdom consistent with worldwide requirements.
The Oncology Middle at Dr. Soliman Fakeeh Hospital – Jeddah is acknowledged for offering complete most cancers care, from early analysis and remedy to long-term follow-up. The middle brings collectively a multidisciplinary group of specialists in surgical oncology, medical oncology, radiation oncology, and pathology, supported by specialised nursing employees, psychological help companies, and scientific diet consultants. Affected person instances are reviewed via a multidisciplinary Tumor Board to develop individualized remedy plans tailor-made to every affected person’s situation.
The middle provides a full spectrum of superior oncology companies, together with advanced oncologic surgical procedure, minimally invasive and robotic-assisted most cancers surgical procedure, chemotherapy, immunotherapy, focused remedy, state-of-the-art radiation remedy, early detection and screening applications, in addition to psychological and rehabilitation help companies for sufferers and their households.
This achievement additional highlights Dr. Soliman Fakeeh Hospital – Jeddah’s management in specialised oncology and hematology care and displays its dedication to delivering superior, patient-centered remedy via internationally acknowledged requirements, supported by cutting-edge know-how and extremely specialised medical experience.
